Insider · CIK 0001135957
Gregg C Johnson
Files at VTSI (VirTra, Inc), VVOS (Vivos Therapeutics, Inc.). First filing -, latest -.
In brief
Gregg C Johnson files SEC Form 4 as director at VTSI (VirTra, Inc), and also at VVOS (Vivos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregg C Johnson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | VVOS Vivos Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +12,000 | $0.00 | $0 | 12,000 | 26 d ago |
| Jun 22, 2026 | VTSI VirTra, Inc | AGrant or award Common Stock | +2,751 | - | - | 13,351 | Jun 24, 2026 |
| Oct 13, 2025 | VTSI VirTra, Inc | AGrant or award Common Stock | +4,000 | - | - | 10,600 | Oct 15, 2025 |
| Oct 18, 2024 | VTSI VirTra, Inc | AGrant or award Common Stock | +4,500 | - | - | 6,600 | Oct 22, 2024 |
Questions about Gregg C Johnson
Answered from the filings on this page, as of the latest one.
Is Gregg C Johnson buying or selling?
Gregg C Johnson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregg C Johnson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregg C Johnson has 0.
Where does Gregg C Johnson file Form 4?
Gregg C Johnson has filed Form 4 at VTSI (VirTra, Inc); VVOS (Vivos Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.